Presentation is loading. Please wait.

Presentation is loading. Please wait.

Late-stage research for diabetes and related NCDs receives little funding: evidence from the NIH RePORTER tool  Pascal Geldsetzer, Till Bärnighausen 

Similar presentations


Presentation on theme: "Late-stage research for diabetes and related NCDs receives little funding: evidence from the NIH RePORTER tool  Pascal Geldsetzer, Till Bärnighausen "— Presentation transcript:

1 Late-stage research for diabetes and related NCDs receives little funding: evidence from the NIH RePORTER tool  Pascal Geldsetzer, Till Bärnighausen  The Lancet Diabetes & Endocrinology  Volume 5, Issue 2, Pages (February 2017) DOI: /S (16) Copyright © 2017 Elsevier Ltd Terms and Conditions

2 Figure US National Institutes of Health spending in fiscal year 2016
NCDs=non-communicable diseases, which include cardiovascular and cerebrovascular disease, diabetes, dyslipidemia, hypertension, and obesity. The Lancet Diabetes & Endocrinology 2017 5, 91-92DOI: ( /S (16) ) Copyright © 2017 Elsevier Ltd Terms and Conditions


Download ppt "Late-stage research for diabetes and related NCDs receives little funding: evidence from the NIH RePORTER tool  Pascal Geldsetzer, Till Bärnighausen "

Similar presentations


Ads by Google